fbpx

Farmworker and Environmental Groups Sue EPA Over Approval of Paraquat

In late September, farmworker and environmental groups sued the Environmental Protection Agency (EPA) over its summer re-approval of the weedkiller paraquat, which is primarily used for soybean, corn, and cotton crop fields. These groups argue that it puts farmworkers at an increased risk for developing Parkinson’s disease, a degenerative brain disease that leads to loss of muscle coordination.

Petition Against EPA’s Decision

The Farmworker Association of Florida (FWAF), along with other groups, petitioned the 9th U.S. Circuit Court of Appeals, asking them to review the EPA’s decision to approve continued use of the herbicide. They claim the weedkiller violates the Federal Insecticide, Fungicide, and Rodenticide Act.

When issuing its July approval, the agency revealed that there was insufficient evidence to link exposure to this herbicide and Parkinson’s disease. However, a growing number of liability lawsuits focus on the connection between paraquat and the degenerative disease. In June, the Judicial Panel on Multi District Litigation (MDL) consolidated the mass tort litigation against paraquat’s makers in the Southern District of Illinois. Because litigation is pending, EPA spokesperson Ken Labbe declined to comment.

Syngenta, one of the herbicide’s major sellers, markets the product as Gramoxone. Spokesperson Paul Minehart declined to comment on the new 9th Circuit case due to a “mandatory quiet period” ahead of its initial public offering on the Shanghai Stock Exchange. The company has previously agreed with the EPA and said there was “no credible evidence” to suggest paraquat usage leads to Parkinson’s.

Paraquat Usage Linked to “Unreasonable Risks”

The plaintiffs, however, said in a statement that some studies have found that paraquat can increase the risk of Parkinson’s. Jeannie Economos, a pesticide safety project coordinator with the FWAF, said that it is “unconscionable that the EPA so devalues the lives of farmworkers as to allow the continued us of this harmful toxic pesticide.” Earthjustice represents the plaintiffs, including FWAF and The Michael J. Fox Foundation for Parkinson’s Research.

The groups also criticized the agency for re-approving the substance despite determining that “exposure to paraquat can damage the respiratory system and eyes,” exposing farmworkers to “unreasonable risks.”

The EPA first registered paraquat in 1964. It must undergo a registration review every 15 years. The product has already been banned in many parts of the world, including by the European Union, China, and Brazil.  

If you or a loved one is impacted by this litigation, please contact us today for a free case evaluation. 

Drug Law Journal Legal Sponsorship

Drug Law Journal's publishing and research are sponsored by the DDP Injury Law Group in Washington, D.C. Their legal team is focused on protecting the rights of injury victims.
Furthermore, they understand and appreciate the importance of a trusted attorney-client relationship.
The DDP Injury Law Group uses their years of experience with litigation to ensure their clients can fight for the compensation they deserve.

Always seek the advice of a medical professional when making personal health choices.

The Offices of DrugLawJournal.com are located at:

1800 North Orange Avenue, Suite C
Orlando, Florida 32804

DrugLawJournal.com is sponsored by the DDP Injury Law Group, and therefore may be considered attorney advertising. The information contained on DrugLawJournal.com is provided for informational purposes only, and should not be construed as legal or medical advice on any subject matter. No viewers of this site should discontinue taking a prescribed medication on the basis of any information on this site and should always first consult with a doctor concerning any medication. Viewers should understand that if they refrain from taking prescribed medication without appropriate medical advice they can suffer injury or death.

No viewers of content from this site, clients or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in the viewer’s state. Viewing information from DrugLawJournal.com does not create an attorney-client relationship between you and DDP Injury Law Group or DrugLawJournal.com nor is it intended to do so.The content of DrugLawJournal.com may not reflect current legal developments, verdicts or settlements. Prior results do not predict a similar outcome. For more information, please visit our web site’s disclaimer.

©2024 DrugLawJournal.com | Privacy Policy | Terms & Conditions

Stay Informed

Sign up to receive peroidic updates from our expert team of researchers, highlighting defective drugs, devices, and legal issues related to your health.

Email Catcher
Free Drug and Medical Device Case Review

Free Drug and Medical Device Case Review

Share your story with us and we will reach out to you about your case.

First
Last
Described what happened to you, we will review and reach out to you about your situation.

It is important for those who have suffered injury from dangerous drugs and medical devices to know that they have may have options.

Consumers have the ability to seek legal remedies for their injuries resulting from the negligence of drug and device manufacturers. The first step toward justice and recovery is sharing your story with effective legal counsel. An attorney will help you to better understand the issues and discuss the possibility of compensation for your suffering.

Once you complete the information request above, Drug Law Journal will send the information to a specialist at our legal sponsor’s firm, the DDP Injury Law Group, in Washington, D.C. That specialist will follow-up with you directly to gather further specific information about your case and make an evaluation. If the firm is able to move forward on your case, they will also discuss next steps. Remember – the entire consult and evaluation is free to you. You only need to take the first step to fill out the contact form or call: (800) 597-1870 for immediate assistance.